BoltzUnclaimed

Boltz is a company building AI models for biology and chemistry. Its models cover biomolecular modeling and design, including proteins and small molecules. The site lists BoltzMol-1 for small-molecule screening and hit discovery, BoltzProt-1, and the open-source Boltz-2 and BoltzGen.

Developers can use the Boltz API from Python, the command line, or TypeScript to run design, structure prediction and affinity pipelines. The site shows a Python example that designs small molecules against a protein target. Deployment can be multi-tenant, single-tenant or on-premise, and the company says it is SOC 2 Type 1 verified. Enterprise customers can fine-tune the models on their own proprietary data, targets and assays.

The product is aimed at drug discovery teams, scientists and companies building agentic science products. The site names Bristol Myers Squibb as a partner and says the models are used by more than 100k scientists and 1k companies, including top 20 pharma companies.

The Boltz Lab has a free tier with up to 200 predictions a month, after which usage-based pricing applies. The page lists small-molecule pipeline runs at $0.025 per molecule, and protein design and structure runs priced by crop size from $0.025 to $0.40. Enterprise pricing is custom and includes single-tenant or private cloud deployment. The company says users own what they create and that customer data is not used to train its models.